Sara Pilotto

Sara Pilotto

Verona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 248 publications

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

Journal: Cancer treatment and research communications
Published: August 25, 2026

Correction: HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes.

Correction: HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes.

Journal: Frontiers in immunology
Published: June 23, 2026

Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision.

Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision.

Journal: Expert review of clinical pharmacology
Published: May 04, 2026

Response to Comment on "Periodizing Exercise Medicine Prescription for Patients with Cancer: A Narrative Opinion".

Response to Comment on "Periodizing Exercise Medicine Prescription for Patients with Cancer: A Narrative Opinion".

Journal: Sports medicine (Auckland, N.Z.)
Published: April 17, 2026

Acute and chronic exercise-conditioned serum effects on cancer cells in vitro: a systematic review.

Acute and chronic exercise-conditioned serum effects on cancer cells in vitro: a systematic review.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: March 27, 2026

Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay.

Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay.

Journal: Expert review of clinical immunology
Published: March 13, 2026

Physical activity level and its determinants in patients with cancer: a secondary analysis using a decision-tree approach.

Physical activity level and its determinants in patients with cancer: a secondary analysis using a decision-tree approach.

Journal: Journal of cancer survivorship : research and practice
Published: February 20, 2026

Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors.

Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors.

Journal: Cancer treatment reviews
Published: February 07, 2026

Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity.

Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity.

Journal: International journal of molecular sciences
Published: January 28, 2026

CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment"

CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment"

Journal: Recenti progressi in medicina
Published: January 22, 2026

Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial.

Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial.

Journal: BMJ open
Published: January 12, 2026

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer
Published: January 11, 2026
Showing 1-12 of 248

Last Updated: 09/26/2026